CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
301017 Shu Yu Civilian Pharmacy Corp.,Ltd.
- 11.20
- +0.29+2.66%
Market Closed Apr 30 15:00 CST
4.54BMarket Cap-26.11P/E (TTM)
11.77High10.96Low69.84KlotVolume10.96Open10.91Pre Close79.19MTurnover2.87%Turnover RatioLossP/E (Static)405.35MShares17.8652wk High2.36P/B2.73BFloat Cap8.8752wk Low13.09Limit Up243.35MShs Float36.15Historical High8.73Limit Down7.42%Amplitude8.87Historical Low0.05Dividend TTM11.34Avg Price29.54KlotAsk0.45%Div YieldTTM100Lot Size37.87KlotBid
Shu Yu Civilian Pharmacy Corp.,Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.48%2.38B | 4.13%9.57B | 8.32%7.08B | 13.08%4.82B | 17.69%2.44B | 17.49%9.19B | 24.53%6.53B | 25.71%4.26B | 30.56%2.07B | 47.00%7.82B |
| Operating revenue | -2.48%2.38B | 4.13%9.57B | 8.32%7.08B | 13.08%4.82B | 17.69%2.44B | 17.49%9.19B | 24.53%6.53B | 25.71%4.26B | 30.56%2.07B | 47.00%7.82B |
| Other operating revenue | ---- | 19.79%83.26M | ---- | -22.56%22.27M | ---- | -39.09%69.51M | ---- | -51.98%28.76M | ---- | 223.76%114.13M |
| Total operating cost | -2.86%2.35B | 7.89%9.71B | 12.18%7.07B | 17.00%4.76B | 21.34%2.42B | 19.88%9B | 23.87%6.3B | 25.28%4.07B | 31.37%1.99B | 44.74%7.5B |
| Operating cost | -0.57%1.76B | 8.43%7.14B | 12.76%5.15B | 18.05%3.48B | 20.68%1.77B | 17.91%6.59B | 22.12%4.57B | 23.44%2.94B | 33.49%1.47B | 46.84%5.59B |
| Operating tax surcharges | -2.74%8.08M | 6.43%34.09M | 7.72%25.6M | 10.23%17.71M | 13.12%8.31M | 10.38%32.03M | 48.18%23.76M | 56.84%16.07M | 55.67%7.35M | 36.44%29.02M |
| Operating expense | -10.68%468M | 6.08%2.08B | 11.32%1.55B | 14.77%1.04B | 23.47%523.93M | 22.20%1.96B | 24.73%1.4B | 24.62%907.81M | 19.53%424.35M | 36.99%1.61B |
| Administration expense | 1.09%74.53M | 4.62%311.04M | 6.44%231.88M | 10.67%158.81M | 19.95%73.72M | 43.39%297.3M | 37.64%217.86M | 48.82%143.5M | 48.23%61.46M | 30.82%207.33M |
| Financial expense | -10.15%33.06M | 16.45%137.36M | 10.85%104.38M | 16.42%69.96M | 28.31%36.79M | 54.67%117.95M | 82.04%94.16M | 100.51%60.09M | 107.28%28.67M | 166.66%76.26M |
| -Interest expense (Financial expense) | 0.19%32.07M | 17.37%138.88M | 17.91%108.02M | 25.18%73.26M | 7.88%32.01M | 61.13%118.33M | 84.40%91.61M | 99.68%58.53M | 119.58%29.67M | 129.60%73.43M |
| -Interest Income (Financial expense) | 10.81%-2.36M | 2.12%-11.33M | 5.80%-8.67M | 6.23%-6.47M | 25.24%-2.65M | -13.49%-11.58M | -33.11%-9.2M | -66.68%-6.9M | -106.24%-3.54M | 3.31%-10.2M |
| Research and development | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --51.06K |
| Credit Impairment Loss | -57.18%-4.91M | -32.93%-33.04M | 55.16%-8.42M | 13.86%-5.89M | -973.59%-3.13M | -59.43%-24.86M | -228.77%-18.77M | 7.07%-6.83M | 89.47%-291.14K | -76.43%-15.59M |
| Asset Impairment Loss | 62.32%-3M | -521.50%-64.74M | -333.06%-27.84M | -328.92%-16.6M | -327.50%-7.97M | -78.45%-10.42M | -59.00%-6.43M | -72.94%-3.87M | -17.21%-1.86M | -187.60%-5.84M |
| Other net revenue | 85.64%-663.44K | -1,652.32%-42.97M | -11.76%-10.95M | -299.86%-7.98M | -159.57%-4.62M | -47.98%2.77M | -290.19%-9.8M | -188.47%-2M | 130.53%7.76M | -85.48%5.32M |
| Fair value change income | ---- | 12,919.10%8.48M | -110.59%-65.12K | -109.61%-65.12K | 173.32%450.19K | -40.00%65.12K | 13.15%614.75K | 30.78%677.41K | 113.28%164.71K | -99.56%108.52K |
| Invest income | -164.63%-313.43K | -59.70%892.49K | 119.13%634.34K | 123.45%1.05M | -79.11%484.97K | 127.40%2.21M | -1,658.46%-3.32M | -3,654.54%-4.49M | 7.98%2.32M | -67.60%973.91K |
| -Including: Investment income associates | 67.69%-313.43K | -310.28%-1.06M | -179.67%-1.38M | -144.45%-961.29K | -183.50%-970.23K | 130.36%502.27K | 212.49%1.73M | 258.64%2.16M | 369.95%1.16M | 9.71%-1.65M |
| Asset deal income | 419.92%2.9M | 121.86%23.05M | 737.10%9.21M | 326.45%4.53M | 438.49%557.65K | 364.52%10.39M | 1,992.06%1.1M | --1.06M | --103.56K | 422.30%2.24M |
| Other revenue | -6.33%4.67M | -11.73%22.39M | -8.71%15.52M | -21.53%8.99M | -31.98%4.98M | 8.29%25.37M | 20.58%17M | 2.27%11.46M | 7.53%7.32M | 14.99%23.43M |
| Operating profit | 70.74%30.43M | -189.89%-178.05M | -100.73%-1.62M | -75.48%45.84M | -79.87%17.82M | -38.89%198.08M | 34.99%223.18M | 32.34%186.95M | 18.69%88.55M | 86.50%324.11M |
| Add:Non operating Income | -33.15%545.29K | 344.27%3.79M | -13.43%2.36M | -14.17%2.06M | 1,441.16%815.68K | -91.83%852.41K | -74.74%2.72M | -77.31%2.4M | -85.42%52.93K | 2,011.88%10.43M |
| Less:Non operating expense | -67.66%1.17M | 83.13%39.08M | 26.27%17.02M | 404.29%13.48M | 723.09%3.62M | 52.44%21.34M | 11.04%13.48M | -77.05%2.67M | -95.13%439.51K | -41.24%14M |
| Total profit | 98.43%29.8M | -220.13%-213.34M | -107.67%-16.29M | -81.56%34.42M | -82.96%15.02M | -44.60%177.59M | 29.55%212.43M | 33.14%186.68M | 33.67%88.17M | 113.04%320.55M |
| Less:Income tax cost | 107.48%7.56M | -122.19%-8.33M | -76.82%12.21M | -60.18%18.38M | -83.17%3.64M | -57.00%37.54M | 37.56%52.69M | 52.58%46.17M | 31.43%21.64M | 141.55%87.3M |
| Net profit | 95.54%22.25M | -246.38%-205.01M | -117.84%-28.5M | -88.59%16.04M | -82.90%11.38M | -39.96%140.05M | 27.11%159.74M | 27.79%140.51M | 34.42%66.53M | 104.02%233.24M |
| Net profit from continuing operation | 95.54%22.25M | -246.38%-205.01M | -117.84%-28.5M | -88.59%16.04M | -82.90%11.38M | -39.96%140.05M | 27.11%159.74M | 27.79%140.51M | 34.42%66.53M | 104.02%233.24M |
| Less:Minority Profit | -488.36%-3.38M | -331.68%-16.2M | -615.79%-15.31M | -655.06%-8.16M | -55.93%869.37K | 83.42%6.99M | 50.72%-2.14M | 193.52%1.47M | 9,543.00%1.97M | 731.70%3.81M |
| Net profit of parent company owners | 143.85%25.62M | -241.90%-188.81M | -108.15%-13.19M | -82.60%24.2M | -83.72%10.51M | -42.01%133.06M | 24.52%161.87M | 24.67%139.04M | 30.38%64.55M | 99.64%229.43M |
| Earning per share | ||||||||||
| Basic earning per share | 100.00%0.06 | -242.42%-0.47 | -107.50%-0.03 | -82.35%0.06 | -81.25%0.03 | -42.11%0.33 | 25.00%0.4 | 21.43%0.34 | 33.33%0.16 | 90.00%0.57 |
| Diluted earning per share | 100.00%0.06 | -242.42%-0.47 | -107.50%-0.03 | -82.35%0.06 | -81.25%0.03 | -42.11%0.33 | 25.00%0.4 | 21.43%0.34 | 33.33%0.16 | 90.00%0.57 |
| Other composite income | ||||||||||
| Total composite income | 95.54%22.25M | -246.38%-205.01M | -117.84%-28.5M | -88.59%16.04M | -82.90%11.38M | -39.96%140.05M | 27.11%159.74M | 27.79%140.51M | 34.42%66.53M | 104.02%233.24M |
| Total composite income of parent company owners | 143.85%25.62M | -241.90%-188.81M | -108.15%-13.19M | -82.60%24.2M | -83.72%10.51M | -42.01%133.06M | 24.52%161.87M | 24.67%139.04M | 30.38%64.55M | 99.64%229.43M |
| Total composite income of minority owners | -488.36%-3.38M | -331.68%-16.2M | -615.79%-15.31M | -655.06%-8.16M | -55.93%869.37K | 83.42%6.99M | 50.72%-2.14M | 193.52%1.47M | 9,543.00%1.97M | 731.70%3.81M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.